EVARF
LOMBARD MEDICAL INC
stock OTC

lombard medical, inc. is an irvine, ca-based medical device company focused on device solutions for the $1.6 billion per year abdominal aortic aneurysm repair market. the company's lead product, aorfix™, is an endovascular stent graft which has been specifically designed to solve the problems that exist in treating complex tortuous anatomies, which are often present in advanced aaa disease. aorfix has been used to treat more than 4,000 patients worldwide. the company's lead product, aorfix™, is the only endovascular stent graft cleared by the u.s. food and drug administration (fda) for the treatment of aaas with angulation at the neck of the aneurysm of up to 90 degrees providing physicians in the u.s. with the only 'on-label' endovascular treatment option for patients with this complex aaa anatomy. all other approved grafts are only cleared by the fda for the treatment of neck angulation up to 60 degrees. for more information, please visit www.lombardmedical.com. lombard medical's s